Assessment of clinical effectiveness of DNA methyltransferase inhibitors and lenalidomide in older patients with refractory anemia with ring sideroblasts with non-del(5q) lower-risk myelodysplastic syndromes
Latest Information Update: 18 Nov 2021
At a glance
- Drugs Lenalidomide (Primary) ; Methyltransferase inhibitors (Primary)
- Indications Anaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
- 18 Nov 2021 New trial record
- 01 Oct 2021 Results published in the Leukemia and Lymphoma